Mostrar el registro sencillo del ítem

dc.contributor.author
Blanco Calvo, Eduardo  
dc.contributor.author
Rivera, Patricia  
dc.contributor.author
Arrabal, Sergio  
dc.contributor.author
Vargas, Antonio  
dc.contributor.author
Pavon, Francisco Javier  
dc.contributor.author
Serrano, Antonia  
dc.contributor.author
Castilla Ortega, Estela  
dc.contributor.author
Galeano, Pablo  
dc.contributor.author
Rubio, Leticia  
dc.contributor.author
Suaréz, Juan  
dc.contributor.author
Rodríguez de Fonseca, Fernando  
dc.date.available
2016-11-01T21:13:25Z  
dc.date.issued
2014-01  
dc.identifier.citation
Blanco Calvo, Eduardo; Rivera, Patricia; Arrabal, Sergio; Vargas, Antonio; Pavon, Francisco Javier; et al.; Pharmacological blockade of either cannabinoid CB1 or CB2 receptors prevents both cocaine-induced conditioned locomotion and cocaine-induced reduction of cell proliferation in the hippocampus of adult male rats; Frontiers; Frontiers in Integrative Neuroscience; 7; 106; 1-2014; 1-13  
dc.identifier.issn
1662-5145  
dc.identifier.uri
http://hdl.handle.net/11336/7900  
dc.description.abstract
Addiction to major drugs of abuse, such as cocaine, has recently been linked to alterations in adult neurogenesis in the hippocampus. The endogenous cannabinoid system modulates this proliferative response as demonstrated by the finding that pharmacological activation/blockade of cannabinoid CB1 and CB2 receptors not only modulates neurogenesis but also modulates cell death in the brain. In the present study, we evaluated whether the endogenous cannabinoid system affects cocaine-induced alterations in cell proliferation. To this end, we examined whether pharmacological blockade of either CB1 (Rimonabant, 3 mg/kg) or CB2 receptors (AM630, 3 mg/kg) would affect cell proliferation (the cells were labeled with BrdU) in the subventricular zone (SVZ) of the lateral ventricle and the dentate subgranular zone (SGZ). Additionally, we measured cell apoptosis (as monitored by the expression of cleaved caspase-3) and glial activation (by analyzing the expression of GFAP and Iba-1) in the striatum and hippocampus during acute and repeated (4 days) cocaine administration (20 mg/kg). The results showed that acute cocaine exposure decreased the number of BrdU-immunoreactive (ir) cells in the SVZ and SGZ. In contrast, repeated cocaine exposure reduced the number of BrdU-ir cells only in the SVZ. Both acute and repeated cocaine exposure increased the number of cleaved caspase-3-, GFAP- and Iba1-ir cells in the hippocampus, and this effect was counteracted by AM630 or rimonabant, which increased the number of BrdU-, GFAP- and Iba1-ir cells in the hippocampus. These results indicate that the changes in neurogenic, apoptotic and gliotic processes that were produced by repeated cocaine administration were normalized by pharmacological blockade of CB1 and CB2. The restorative effects of cannabinoid receptor blockade on hippocampal cell proliferation were associated with the prevention of the induction of conditioned locomotion but not with the prevention of cocaine-induced sensitization.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Frontiers  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
Cocaina  
dc.subject
Neurogenesis  
dc.subject
Cannabinoid Receptors  
dc.subject
Rimonabant  
dc.subject
Am630  
dc.subject
Inflammation  
dc.subject
Hippocampus  
dc.subject
Striatum  
dc.subject.classification
Neurociencias  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Pharmacological blockade of either cannabinoid CB1 or CB2 receptors prevents both cocaine-induced conditioned locomotion and cocaine-induced reduction of cell proliferation in the hippocampus of adult male rats  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2016-08-30T17:09:49Z  
dc.journal.volume
7  
dc.journal.number
106  
dc.journal.pagination
1-13  
dc.journal.pais
Suiza  
dc.journal.ciudad
Lausanne  
dc.description.fil
Fil: Blanco Calvo, Eduardo. Universitat de Lleida; España  
dc.description.fil
Fil: Rivera, Patricia. Universidad de Malaga; España  
dc.description.fil
Fil: Arrabal, Sergio. Universidad de Malaga; España  
dc.description.fil
Fil: Vargas, Antonio. Universidad de Malaga; España  
dc.description.fil
Fil: Pavon, Francisco Javier. Universidad de Malaga; España  
dc.description.fil
Fil: Serrano, Antonia. Universidad de Malaga; España  
dc.description.fil
Fil: Castilla Ortega, Estela. Universidad de Malaga; España  
dc.description.fil
Fil: Galeano, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas (i); Argentina  
dc.description.fil
Fil: Rubio, Leticia. Universidad de Malaga; España  
dc.description.fil
Fil: Suaréz, Juan. Universidad de Malaga; España  
dc.description.fil
Fil: Rodríguez de Fonseca, Fernando. Universidad de Malaga; España  
dc.journal.title
Frontiers in Integrative Neuroscience  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884150/  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fnint.2013.00106/full  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3389/fnint.2013.00106